Overview

Argatroban Versus Lepirudin in Critically Ill Patients

Status:
Terminated
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the hypotheses that argatroban significantly increases efficacy and safety of renal replacement therapy measured as life time of haemodialysis filters as compared to lepirudin
Phase:
Phase 4
Details
Lead Sponsor:
Heinrich-Heine University, Duesseldorf
Treatments:
Antithrombins
Argatroban
Hirudins
Lepirudin